AI Article Synopsis
- Malignant peritoneal mesothelioma (MPM) is a rare cancer with a poor prognosis and is not commonly treated with surgery, particularly for cases of recurrence.
- Early diagnosis and aggressive treatment may lead to long-term survival for patients with this disease.
- The case discussed in the article highlights a patient who survived long-term after undergoing two surgeries for MPM over four years.
Article Abstract
Key Clinical Message: Malignant peritoneal mesothelioma, a rare and poor prognosis disease, is seldom treated surgically, especially for recurrence. However, early diagnosis and aggressive treatment of primary and recurrent tumors can achieve long-term patient survival.
Abstract: Malignant peritoneal mesothelioma (MPM) is a rare and aggressive tumor, and rarely indicated for surgery, especially for recurrence. In the present case, we report a rare case who could survive long-term after two surgeries in 4 years for MPM.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10196420 | PMC |
| http://dx.doi.org/10.1002/ccr3.7383 | DOI Listing |
Publication Analysis
Top Keywords
malignant peritoneal
12
peritoneal mesothelioma
12
case report
8
recurrent malignant
4
mesothelioma treated
4
treated second
4
second resection
4
resection case
4
report key
4
key clinical
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!